Godavari Drugs Ltd.
Snapshot View

63.80 +1.60 ▲2.6%

25 November 2022, 04:01:00 PM
Volume: 3,277

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.godavaridrugs.com
Market Cap 47.33 Cr.
Enterprise Value(EV) 77.27 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 5.82 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 10.80 Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 41.72 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.51 Calculated using Price: 62.85
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.75 Cr. 7,530,500 Shares
FaceValue 10
Company Profile
The company's principal activity is to manufacture and sell bulk drugs. It undertakes contract manufacturing from various organizations. The products include Pyrazinamide and Ethambutol HCL.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.57%
1 Week
+1.84%
1 Month
-7.94%
3 Month
-6.73%
6 Month
-5.62%
1 Year
+10.86%
2 Year
+86.28%
5 Year
+72.43%
10 Year
+565.28%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 17.77 32.32 9.84 11.81 4.99 6.85 10.39 18.49 19.42
Return on Capital Employed (%) 8.18 32.30 15.77 16.89 11.01 12.14 11.80 17.58 18.35
Return on Assets (%) 10.41 14.70 3.17 3.41 1.40 1.77 2.54 4.72 5.45

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 10 13 14 16 17 18 20 24 30 31
Non Curr. Liab. 2 5 5 6 9 9 12 16 14 13
Curr. Liab. 3 17 31 34 37 46 51 51 58 79
Minority Int.
Equity & Liab. 15 35 51 56 63 74 84 91 101 124
Non Curr. Assets 8 8 10 13 16 17 23 24 27 31
Curr. Assets 6 27 40 43 47 56 61 68 74 93
Misc. Exp. not W/O
Total Assets 15 35 51 56 63 74 84 91 101 124

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 9 55 71 76 64 84 96 123 161 161
Other Income 0 0 0 1 1 0 0 0 0 0
Total Income 10 55 71 76 65 84 96 123 161 162
Total Expenditure -8 -49 -67 -70 -60 -78 -90 -113 -150 -151
PBIDT 2 6 5 6 5 6 6 10 12 11
Interest 0 -1 -2 -3 -2 -3 -3 -3 -3 -3
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -2 -2
Taxation 1 -1 -1 -1 0 -1 0 -2 -2 -1
Exceptional Items
PAT 2 4 1 2 1 1 2 4 5 4
Adjusted EPS 2 5 2 2 1 2 3 5 7 6

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 1 2 -6 -5 5 4 4 6 1 11
Cash Fr. Inv. -1 -2 0 -2 -3 -3 -2 -7 -1 -5
Cash Fr. Finan. 1 0 6 7 -2 0 -1 0 0 -6
Net Change 0 0 0 0 0 1 0 0 0 1
Cash & Cash Eqvt 0 0 0 1 1 2 2 1 2 2

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 55.86 55.86 55.86 56.13 56.13 56.13 56.36 56.92 56.92
Public 44.14 44.14 44.14 43.87 43.87 43.87 43.64 43.08 43.08
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 11.55 11.55 14.09 14.51 14.51 5.18 5.16 5.11 5.11

Announcements View Details >>

Sat, 26 Nov 2022
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Fri, 25 Nov 2022
Announcement Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 Read With SEBI (Prohibition Of Insider Trading) Regulations 2015 [Regulation 7(2) Read With Regulation 6(2)]
Announcement under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations 2011 read with SEBI (Prohibition of Insider Trading) Regulations 2015 [Regulation 7(2) read with Regulation 6(2)]
Sat, 12 Nov 2022
Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th November 2022
Outcome of Board Meeting held on 12th November 2022 for approval of unaudited Financial Statements for the quarter ended September 2022

Technical Scans View Details >>

Fri, 25 Nov 2022
Making Lower Lows for 3 days Making Lower Lows for 3 days
High Decrease 1 Month High Decrease 1 Month
High Increase 2 Years High Increase 2 Years
MFI Crossed 20 From Above MFI Crossed 20 From Above
MFI Below 20 MFI Below 20

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Godavari Drugs Ltd.

What is Godavari Drugs share price?

Can I buy Godavari Drugs shares now?

What is the Market Cap of Godavari Drugs?

What are the key metrics to analyse Godavari Drugs?

What is the 52 Week High and Low of Godavari Drugs?

What is the trend of Godavari Drugs share price?